Scientists Found the Gut Bacterium That Might Be Sabotaging Your Sleep

If you've spent months chasing your insomnia back to stress, screens, or bad sleep hygiene with no luck, a new study points somewhere you probably haven't looked: your gut. Researchers in Hong Kong tracked down a specific bacterium that's consistently missing from the guts of people with chronic insomnia, and showed that giving it back – or just giving mice the molecule it produces – restored normal sleep. The mechanism they uncovered runs straight through the stress-hormone system that keeps you lying awake at 3 a.m.

Key takeaways:

• A bacterium called Faecalibacterium prausnitzii was consistently depleted in the guts of 171 people with insomnia, alongside a drop in its byproduct, the amino acid L-arginine.
• In mice, restoring either the bacterium or L-arginine directly reversed stress-induced sleep loss by calming the hormone pathway (POMC-ACTH-cortisol) that drives the body's stress response.
• The human findings are observational (a snapshot, not a before-and-after), and the mechanism was proven in mice, not people – there's no human trial of F. prausnitzii or L-arginine for insomnia yet.
• Don't start supplementing L-arginine for sleep based on this alone; the safe and effective dose in humans hasn't been established.

Faecalibacterium prausnitzii depletion is a shared signature of insomnia

Researchers from the Chinese University of Hong Kong found that a single gut bacterium, Faecalibacterium prausnitzii – already known from independent research on gut inflammation as one of the microbiome's most consistently protective, anti-inflammatory species – was the one species consistently missing across two different types of insomnia, according to a study published in Cell Reports Medicine. The team sequenced stool samples from 171 people – 57 with primary insomnia, 57 recovering from post-COVID insomnia, and 57 controls with normal sleep – and screened over 1,600 microbial species. Only one, F. prausnitzii, was significantly reduced in both insomnia groups compared to people who slept normally. The same pattern showed up at the functional level: pathways the gut microbiome uses to build the amino acid L-arginine (a building block the body uses to make proteins and, in this case, appears to also use as a signal to the brain) were depleted across both insomnia groups too.

Chronic insomnia and post-COVID sleep problems both showed the same gut signature

Insomnia is common enough to be a public-health issue in its own right – recent CDC survey data puts trouble falling or staying asleep at roughly 15-18% of US adults – and that's before accounting for people whose sleep problems trace back to a specific trigger like a viral infection. What makes this study notable for that group specifically is that the researchers didn't just study "insomnia" as one bucket: they compared primary insomnia (no clear external trigger) against post-COVID insomnia, and found the same F. prausnitzii and L-arginine depletion in both. If you've been told your post-COVID sleep problems are "just stress" or "just anxiety," this is early evidence there may be a measurable microbial and hormonal signature involved too – though it's not yet something a clinician can test for or treat based on this study alone.

A four-week stress model in mice tied the bacterium directly to sleep and cortisol

To move beyond correlation, the team ran a controlled experiment most human studies can't: a chronic mild stress (CMS) mouse model, in which mice are subjected to unpredictable low-grade stressors for four weeks until they develop shortened, disrupted sleep and elevated stress hormones – a reasonable animal stand-in for chronic insomnia. Stressed mice that then received either live F. prausnitzii or L-arginine directly saw their sleep duration return to normal control levels within a week, and their corticosterone (the rodent equivalent of cortisol) normalized alongside it. The bacteria and the amino acid produced essentially the same result, supporting the idea that L-arginine is the active ingredient the bacterium is providing.

What this could mean if your sleep problems trace back to chronic stress

For someone whose insomnia tracks closely with stress or anxiety, the practical takeaway isn't "take L-arginine" – the study doesn't establish a safe or effective human dose, and supplementing an amino acid isn't the same as growing more of the bacterium that produces it in your gut. What it does add is a concrete, testable mechanism worth discussing with a doctor if you're already investigating a gut-related cause for insomnia: the researchers showed that L-arginine directly suppresses POMC, a gene that kicks off the hormonal chain reaction (POMC to ACTH to cortisol) your body uses to stay alert under stress – the same HPA axis pathway that NIH-published research has long linked to insomnia and disrupted sleep architecture. Blocking that chain earlier – via a gut-derived molecule rather than a drug acting on the brain directly – is a genuinely new angle on an old problem, even though it isn't a treatment you can act on yet.

The human data is a snapshot, not a before-and-after

The biggest caveat is design: the human portion of this study is cross-sectional, meaning researchers measured gut bacteria and hormones at a single point in time across 171 people rather than tracking the same individuals as their sleep and microbiome changed. That means it can show F. prausnitzii and insomnia travel together, but not that low F. prausnitzii causes insomnia in people – only the mouse experiments, run in a much smaller sample (six mice per group), demonstrate that direction of cause and effect. No human trial of F. prausnitzii supplementation, or of L-arginine specifically for insomnia, has been conducted. The researchers themselves note their post-COVID insomnia cohort may not generalize to insomnia caused by chronic pain, depression, or medication.

Human trials of the bacterium or the amino acid are the logical next step

The authors frame F. prausnitzii and L-arginine as "potential therapeutic avenues," language that signals early-stage, hypothesis-generating work rather than a near-term treatment. The next scientifically meaningful step would be a controlled human trial – either supplementing L-arginine directly or administering F. prausnitzii as a live bacterial product – in people with diagnosed insomnia, with sleep tracked over time rather than measured once. Until that happens, this remains a mechanism worth watching, not a fix worth trying.

Common questions

Can I just take L-arginine supplements to sleep better? Not based on this study. The dose used in animal and cell experiments hasn't been tested for safety or effectiveness in humans with insomnia, and taking a supplement is different from restoring a bacterium's natural production of it in your gut.

Is F. prausnitzii available as a probiotic? Not currently as a clinically validated insomnia treatment. F. prausnitzii is a difficult-to-culture anaerobic bacterium studied mainly in the context of gut inflammation, and no human sleep trial using it exists yet.

Does this mean stress causes insomnia through the gut, or does insomnia disrupt the gut? The study can't fully separate the two in humans, since the human data is a single snapshot. The mouse experiments suggest stress disrupts the gut microbiome and hormone levels together, and that restoring the missing bacterium or its metabolite can interrupt that cycle either way.

Is this specific to post-COVID insomnia or all insomnia? The gut and hormone signature was consistent across both primary insomnia and post-COVID insomnia in this study, suggesting a shared mechanism rather than something unique to COVID – though the cohort didn't include other secondary insomnia causes like chronic pain or depression.

References

1. Yun Wang, Suyi Xie, Chenyu Li, et al. (2026). Faecalibacterium prausnitzii-derived L-arginine ameliorates insomnia by inhibiting POMC-ACTH-cortisol axis. Cell Reports Medicine. https://doi.org/10.1016/j.xcrm.2026.102997
2. Harry Sokol, Bénédicte Pigneur, Laurie Watterlot, et al. (2008). Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0804812105
3. Short Sleep Duration and Sleep Difficulties Among Adults: United States, 2024 – CDC. cdc.gov. https://www.cdc.gov/nchs/products/databriefs/db559.htm
4. HPA Axis and Sleep – Endotext, NCBI Bookshelf (NIH). NIH. https://www.ncbi.nlm.nih.gov/books/NBK279071/